CNBC Top News

Cập nhật về kinh doanh từ CNBC (link bài bên dưới)

• Companies from Chipotle to Delta are worried about Trump's tariffs. Here's what they're saying

  PepsiCo, Chipotle and Procter & Gamble are among the companies that lowered their forecasts.

• March home sales drop to their slowest pace since 2009

  Home sales in March were weaker than expected, due to higher mortgage rates and concern over the broader economy.

• American liquor exports hit record high in 2024, driven by tariffs

  U.S. Spirits exports reached a record $2.4 billion in 2024 driven in large part by tariff fears.

• Hasbro forecasts as much as $300 million impact if China tariffs don't come down

  Hasbro CEO Chris Cocks said the company will be forced to raise prices and warned of potential job losses as the company tries to absorb costs.

• American Airlines withdraws 2025 forecast on murky economic outlook

  American Airlines joined Delta, Southwest and Alaska in pulling its 2025 financial guidance.

• PepsiCo cuts earnings forecast as it predicts 'uncertainty' in tariffs, consumer spending

  PepsiCo cut its forecast for its core constant currency earnings per share, citing new tariffs.

• Procter & Gamble CEO says price hikes are 'likely,' as Tide owner cuts outlook due to tariffs, uncertainty

  Procter & Gamble's quarterly earnings topped estimates, but its revenue fell short of expectations.

• Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs

  The guidance revisions include the estimated impact of current tariffs on U.S. products shipped to China, but not Trump's planned pharmaceutical tariffs.

• Comcast stock drops as investors balk at weakness in broadband

  Comcast lost 199,000 total domestic broadband customers, reflecting the continued pressure on the cable giant's cornerstone business.

• Merck lowers profit outlook, partly due to $200 million expected tariff hit

  Merck said the expected tariff charge primarily reflects levies between the U.S. and China, but does not account for Trump's planned pharmaceutical tariffs.